Pharmacare arrangements vary from province to province.
As I understand it (a quick Google), seniors in BC pay a maximum co-pay of $25 per prescription, $275 annual cap. In Ontario, it's $2 per prescription, $100 annual cap. I believe people with "drug cards" -- people on social assistance or the working poor up to some level -- pay the same co-pay. Many pharmacies in Ontario, like my local independent guy in a low-income neighbourhood, don't charge the co-pay.
A person on unemployment benefits would qualify if their income was below the cut-off for a drug card, but they would have to apply for and receive the card.
I'm self-employed, high income. No drug benefits. For me to buy into a private plan, even if I could find one, would cost more than it's worth. Mind you, with the co-vivant having just started on insulin ...
People employed with major employers generally have the kind of supplemental insurance coverage described here, i.e. have the option of buying in; it's usually paid 50-50 by the employer and employee. It will cover dental, eyeglasses, drugs and a certain number of pyschotherapy sessions, for example.
My co-vivant is also on Lipitor, but gets samples from his doc at the community clinic where we choose to be patients (rather than going to a doc in private practice), I suspect because most of her clients have drug cards, and others have supplemental private insurance through their jobs. So I don't know what it would cost otherwise. Possibly what you said, but I don't imagine quite that much.
Here's a rather technical article about prescription drug policy in Canada:
http://www.expressnews.ualberta.ca/article.cfm?id=4737... our enormous neighbour to the south is further muddying the waters when it comes to pharmacare. The U.S. industry lobby group PhRMA has funded a million-dollar lobbying campaign to "change the Canadian health-care system." This means they want to raise the price of prescription drugs in Canada to those of the U.S. Frankly, Canadians' access to medications is in enough trouble without U.S. interference. Our policymakers need to show some intestinal fortitude on this issue. There is a principle worth defending here: the preservation of the Canadian approach to health care, characterized by a strong belief in the rights and interests of patients.
One reason that NAFTA is a subject of concern is that it could very well prevent Canada from implementing a national pharmacare program, thereby ousting USAmerican insurance companies from the prescription drug insurance market. Those companies would have standing to challenge Canada's legislation.
An article in the Canadian Medical Association Journal about the lack of attention to pharmacare, and particularly the need for catastrophic out-patient drug coverage. (If you're in the hospital, your drugs are free; if you're taking an expensive anti-cancer drug at home, say, you pay for it.)
http://www.cmaj.ca/cgi/content/full/171/6/565One gaping hole in Canadian medicare is the lack of universal public insurance for outpatient drugs. The benefits of prescription drugs are undeniable, but their full potential, as Roy Romanow noted in the report of his Royal Commission, will be realized only once they are fully integrated into the health care system in a way that ensures their appropriate utilization.
Still, because prescription drugs are almost always considerably cheaper in Canada (as a result of the govt's negotiations with the pharmaceutical companies), the issue isn't a big one for most people.
Another commentary, from the Canadian Cancer Society:
http://www.bc.cancer.ca/ccs/internet/standard/0,2939,3278_335421_363674_langId-en,00.htmlAha -- finally: a paper prepared for Health Canada on the subject. This is its summary of existing provisions (I've never had them at all straight in my own head, you see).
http://www.hc-sc.gc.ca/iacb-dgiac/arad-draa/english/rmdd/wpapers/pharma02.htmlEven though the Canada Health Act does not require the provinces to offer coverage of pharmaceuticals (except for patients in hospital), all provinces have plans that pay for the drugs of individuals receiving social assistance, and all but two have plans that cover every individual older than age 65. (The exceptions are New Brunswick and Newfoundland, whose plans only cover senior citizens with income low enough to qualify for the guaranteed income supplement.)
In addition to the plans that cover all senior citizens and social assistance recipients, the western provinces, Ontario and Quebec have at least some type of coverage that is available to all citizens, although in some cases with very high deductible provisions. Among this group, Quebec is unique in that it has a plan under which pharmaceutical insurance is mandatory. However, those who are eligible for private group insurance through their employer do not have to enroll in the public plan (indeed, are not allowed to do so).
<I'm in Ontario, and frankly I had no idea that Ontario offered such a plan to anyone other than seniors and low-income people.>
Most of the provincial/territorial plans are tax-financed, although there are some exceptions. In Quebec, those insured under the public plan have to pay an annual premium, determined on the basis of net income, that varies from $0 to $350 per adult per year. The premium is collected annually through the provincial/territorial income tax system.
Alberta offers an extended health benefits plan, which includes drugs for those not covered by plans for seniors and social assistance recipients, at a three-month premium of $123 per family. In both cases, premium subsidies apply to those with low income. In Nova Scotia, seniors must pay a premium of $215, while seniors in New Brunswick who do not qualify for low-income coverage have to pay a monthly premium of $58 per person.
Most plans have either deductibles or some type of co-insurance or co-payment provision; several provinces have both. In many cases, deductibles and stop-loss provisions14 differ by categories of beneficiaries, or are computed according to the beneficiaries' income (e.g. Manitoba, Ontario's Trillium plan). In some cases, the deductibles and co-insurance provisions of the residual plans for people who do not have low incomes are so high that the plan may be best characterized as catastrophe insurance. Thus, the standard deductible in Saskatchewan's residual plan is $850 per six months, and there is a co-insurance provision of 35 percent of the cost of each prescription thereafter. In B.C., the corresponding plan has an annual deductible of $600, followed by co-insurance of 30 percent, with an annual patient payment ceiling of $2,000. The public plan in Quebec has a smaller cost-sharing element: a three-monthly deductible of $25 per adult, and then co-insurance of 25 percent of the prescription cost, up to a total ceiling of $187.50 per three months (lower for those with low income). In the Maritime provinces, there are no deductibles, though some co-payments apply.